Skip to main content
. Author manuscript; available in PMC: 2020 Mar 24.
Published in final edited form as: Curr Cardiol Rep. 2019 Nov 25;21(12):152. doi: 10.1007/s11886-019-1238-1

Fig. 3.

Fig. 3

FDG-PET of a 63-year-old female on methotrexate for cardiac sarcoidosis before (a) and during (b) therapy with methotrexate for 2 years, exhibiting a significant decrease in FDG uptake in the heart suggesting adequate response to therapy. The scan continues to show FDG uptake in mediastinal lymph nodes